- Report
- May 2024
- 182 Pages
Global
From €4672EUR$4,900USD£4,004GBP
- Report
- February 2024
- 115 Pages
Global
From €4529EUR$4,750USD£3,882GBP
- Report
- August 2023
- 300 Pages
Global
From €4572EUR$4,795USD£3,919GBP
- Report
- June 2019
- 112 Pages
Global
From €4720EUR$4,950USD£4,045GBP
- Report
- July 2022
- 94 Pages
Europe
From €1430EUR$1,500USD£1,226GBP
- Report
- November 2021
- 228 Pages
Global
From €3433EUR$3,600USD£2,942GBP
- Report
- October 2021
- 299 Pages
Global
From €3539EUR$3,712USD£3,034GBP
- Book
- February 2024
- 928 Pages
The Ultra Pure Proteins market is a subset of the Drug Discovery market, which focuses on the development of new drugs and treatments. Ultra Pure Proteins are proteins that have been purified to a high degree, allowing for more accurate and reliable results in drug discovery. These proteins are used in a variety of drug discovery processes, such as target identification, drug screening, and drug development. Ultra Pure Proteins are also used in the production of biopharmaceuticals, which are drugs produced using biotechnology.
The Ultra Pure Proteins market is highly competitive, with many companies offering a range of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, Sigma-Aldrich, Bio-Rad Laboratories, and Promega Corporation. Show Less Read more